ArrowMark Colorado Holdings’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.9M | Sell |
|
|||||
|
2025
Q1 | $11.9M | Buy |
|
|||||
|
2024
Q4 | $10.3M | Sell |
|
|||||
|
2024
Q3 | $13.3M | Sell |
|
|||||
|
2024
Q2 | $11.4M | Sell |
|
|||||
|
2024
Q1 | $13.2M | Sell |
|
|||||
|
2023
Q4 | $12.5M | Sell |
|
|||||
|
2023
Q3 | $13.2M | Sell |
|
|||||
|
2023
Q2 | $13.9M | Buy |
|
|||||
|
2023
Q1 | $9.54M | Buy |
|
|||||
|
2022
Q4 | $10.7M | Sell |
|
|||||
|
2022
Q3 | $11.9M | Sell |
|
|||||
|
2022
Q2 | $11.2M | Sell |
|
|||||
|
2022
Q1 | $13.1M | Buy |
|
|||||
|
2021
Q4 | $15M | Buy |
|
|||||
|
2021
Q3 | $14.1M | Buy |
|
|||||
|
2021
Q2 | $12M | Sell |
|
|||||
|
2021
Q1 | $16.1M | Sell |
|
|||||
|
2020
Q4 | $20.4M | Sell |
|
|||||
|
2020
Q3 | $17.8M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $19.7M | Sell |
|
|||||
|
2019
Q4 | $25.3M | Buy |
|
|||||
|
2019
Q3 | $17.4M | Buy |
|
|||||
|
2019
Q2 | $24.2M | Buy |
|
|||||
|
2019
Q1 | $29.1M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $26.5M | Buy |
|
|||||
|
2018
Q2 | $2.61M | Buy |
|